1 Ogunbiyi J O. Hepatocellular carcinoma in the developing world. Semin Oncol, 2001, 28: 179-187？？
[2]
2 Zhou X D, Tang Z Y, Yang B H, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer,2001, 91: 1479-1486？？
[3]
3 Yang J M, Kan T, Chen H, et al. Hepatectomy in the treatment of very big primary liver cancer: report of 86 cases. Hepatobiliary PancreatDis Int, 2002, 1: 42-45
[4]
4 Song T J, Ip E W, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology, 2004, 127(Suppl 1): 248-260？？
[5]
5 Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellularcarcinoma after hepatectomy. J Hepatol, 2003, 38: 200-207
[6]
6 Joong-Won P. Practice guidelines for management of hepatocellular carcinoma 2009. Korean J Hepatol, 2009, 15: 391-423？？
[7]
7 Hasegawa H, Matsumiya S, Uchiyama M, et al. Inhibitory effect of some triterpenoid saponins on glucose transport in tumor cells and itsapplication to in vitro cytotoxic and antiviral activities. Planta Med, 1994, 60: 240-243？？
[8]
8 Zhou W, Li J, Li X, et al. Development and validation of a reversed-phase HPLC method for quantitative determination of ginsenosides Rb1,Rd, F2, and compound K during the process of biotransformation of ginsenoside Rb1. J Sep Sci, 2008, 31: 921-925
[9]
9 Wakabayashi C, Hasegawa H, Murata J, et al. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinalbacterial metabolites after oral administration. Oncol Res, 1997, 9: 411-417
[10]
10 Hasegawa H, Lee K S, Nagaoka T, et al. Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation tobiologically active fatty acid esters. Biol Pharm Bull, 2000, 23: 298-304
[11]
11 Ming Y L, Song G, Chen L H, et al. Anti-proliferation and apoptosis induced by a novel intestinal metabolite of ginseng saponin in humanhepatocellular carcinoma cells. Cell Biol Int, 2007, 31: 1265-1273？？
[12]
12 Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora''s box opens. Nat Rev Mol Cell Biol, 2001, 2: 67-71？？
[13]
13 Oh S H, Lee B H. A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and itsdownstream caspase-8 activation and Bid cleavage. Toxicol Appl Pharmacol, 2004, 194: 221-229？？
[14]
14 Volm M, Koomagi R, Mattern J. PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association withlymph node metastasis. Anticancer Res, 1999, 19: 651-655
[15]
15 Yosioka I, Sugawara T, Imai K, et al. Soil Bacterial hydrolysis: leading to Genuine Aglycone V on Ginsenosides-Rb1, Rb2, and Rc of theGinseng Root Saponins. Chem Pharm Bull, 1972, 11: 2418-2421
[16]
16 Lee B H, Lee S J, Hur J H, et al. In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria. PlantaMed, 1998, 64: 500-503
[17]
17 Lee S J, Ko W G, Kim J H, et al. Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediatedactivation of caspase-3 protease. Biochem Pharmacol, 2000, 60: 677-685？？
[18]
18 Choo M K, Sakurai H, Kim D H, et al. A ginseng saponin metabolite suppresses tumor necrosis factor-alpha-promoted metastasis bysuppressing nuclear factor-kappaB signaling in murine colon cancer cells. Oncol Rep, 2008, 19: 595-600
[19]
19 Kim S, Kang B Y, Cho S Y, et al. Compound K induces expression of hyaluronan synthase 2 gene in transformed human keratinocytes andincreases hyaluronan in hairless mouse skin. Biochem Biophys Res Commun, 2004, 316: 348-355？？
[20]
20 Choo M K, Park E K, Han M J, et al. Antiallergic activity of ginseng and its ginsenosides. Planta Med, 2003, 69: 518-522？？
[21]
21 Shin Y W, Bae E A, Kim S S, et al. Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis. IntImmunopharmacol, 2005, 5: 1183-1191
[22]
22 Lee H U, Bae E A, Han M J, et al. Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liverinjury. Liver Int, 2005, 25: 1069-1073？？
[23]
23 Tohda C, Matsumoto N, Zou K, et al. Abeta(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1,A metabolite of protopanaxadiol-type saponins. Neuropsychopharmacology, 2004, 29: 860-868
[24]
24 Townson J L, Naumov G N, Chambers A F. The role of apoptosis in tumor progression and metastasis. Curr Mol Med, 2003, 3: 631-642？？
[25]
25 Wakabayashi C, Murakami K, Hasegawa H, et al. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability toinduce apoptosis in tumor cells. Biochem Biophys Res Commun, 1998, 246: 725-730？？
[26]
26 Chae S, Kang K A, Chang W Y, et al. Effect of compound K, a metabolite of ginseng saponin, combined with gamma-ray radiation inhuman lung cancer cells in vitro and in vivo. J Agric Food Chem, 2009, 57: 5777-5782？？
[27]
27 Stafford L J, Vaidya K S, Welch D R. Metastasis suppressors genes in cancer. Int J Biochem Cell Biol, 2008, 40: 874-891？？
[28]
28 Hasegawa H, Sung J H, Huh J H. Ginseng intestinal bacterial metabolite IH901 as a new anti-metastatic agent. Arch Pharm Res, 1997, 20:539-544？？
